This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
Provia Laboratories announces the addition of Dr. Jim Vaught, Ph.D. to its growing Advisory Board. Dr. Vaught has worked in the field of biorepository and biospecimen science for over 20 years and is one of the founding members of ISBER.
Littleton, MA (PRWEB) July 18, 2014
Provia Laboratories announces the addition of Dr. Jim Vaught, Ph.D. to its growing Advisory Board. Dr. Vaught has worked in the field of biorepository and biospecimen science for over 20 years. As one of the founding members of ISBER the International Society for Biological and Environmental Repositories - in 1999, he served as its second president, and 15 years later he is again president-elect.
In 2005, Dr. Vaught began working with the National Institutes of Health (NIH) in the Office of Biorepositories and Biospecimen Research (OBBR), part of the National Cancer Institute (NCI). He worked specifically on the development of the NCIs Best Practices for Biospecimen Resources. From 2005 to 2013 Dr. Vaught served as the NIHs representative to the Interagency Working Group on Scientific Collections, created by the Office of Science and Technology Policy. Additionally, he also served as a member of the NIH Intramural Scientific Directors Biorepository Committee.
In addition to ISBER, Dr. Vaught is a member of the American Association for Cancer Research (AACR), the American Society for Pharmacology and Experimental Therapeutics and the American Association for Clinical Chemistry. From 2006 to 2012 he was Senior Editor for Biorepository and Biospecimen Science for the AACR journal Cancer Epidemiology, Biomarkers and Prevention. Since 2012 he has been Editor-in-Chief of Biopreservation and Biobanking, the official journal of ISBER.
Dr. Vaught is currently an advisory board member for Biobanques (France) and The Telethon Network of Genetic Biobanks (Italy). Most Recently, until October 2013, Dr. Vaught served as Chief, Biorepositories and Biospecimen Research Branch (BBRB), Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH.
We are delighted to add to our team someone with such deep expertise and who has committed 20 years of their life to advancing the critical field of biobanking, said Howard Greenman, CEO of Provia Labs. Greenman continues, The methods involved in ensuring precision in this field are complicated, but are instrumental to the advancement of therapies both as mechanisms to provide high quality biomaterial to the research community, but also to ensure patients samples collected at one point in time can be used in the future - safely and effectively.
Dr. Vaughts addition to the Provia Advisory Board is part of an aggressive plan to grow Provias emerging Commercial Biobanking Division which currently offers Biobanking Management Consulting services, biobanking products such as the Proviasette an optimized storage container for storing solid tissue samples at ultra-cold temperatures (http://www.proviasette.com), and includes a growing business around repository management services. Provia recently moved its corporate headquarters to a large facility in Littleton, MA where it is expanding its repository to support this growth.
Additionally, Dr. Vaught will assist Provia in its core business unit its Consumer Biobanking Division which includes Store-A-ToothTM (http://www.store-a-tooth.com), a consumer service for the private banking of valuable, non-controversial adult stem cells found in childrens teeth for future clinical use. Dr. Vaughts expertise will assist Provia in expanding processing and storage capacity for Store-A-Tooth customer samples.
About Provia Laboratories, LLC
Provia Laboratories, LLC (http://www.provialabs.com) is a health services company specializing in high quality biobanking (the collection, transport, processing, and cryogenic storage of biological specimens). Its dental stem cell banking service, Store-A-ToothTM, gives parents the option to store stem cells today to protect their childrens health tomorrow. Store-A-Tooth preserves stem cells from baby and wisdom teeth that would otherwise be discarded, so parents can be prepared for advances in stem cell therapies that someday may help treat conditions such as type 1 diabetes, spinal cord injury, heart attack, stroke, and neurological disorders like Parkinsons and Alzheimers.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/07/prweb12026575.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.